Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387661902> ?p ?o ?g. }
- W4387661902 endingPage "83" @default.
- W4387661902 startingPage "1" @default.
- W4387661902 abstract "Antidepressants are commonly prescribed during pregnancy, despite a lack of evidence from randomised trials on the benefits or risks. Some studies have reported associations of antidepressants during pregnancy with adverse offspring neurodevelopment, but whether or not such associations are causal is unclear.To study the associations of antidepressants for depression in pregnancy with outcomes using multiple methods to strengthen causal inference.This was an observational cohort design using multiple methods to strengthen causal inference, including multivariable regression, propensity score matching, instrumental variable analysis, negative control exposures, comparison across indications and exposure discordant pregnancies analysis.This took place in UK general practice.Participants were pregnant women with depression.The interventions were initiation of antidepressants in pregnancy compared with no initiation, and continuation of antidepressants in pregnancy compared with discontinuation.The maternal outcome measures were the use of primary care and secondary mental health services during pregnancy, and during four 6-month follow-up periods up to 24 months after pregnancy, and antidepressant prescription status 24 months following pregnancy. The child outcome measures were diagnosis of autism, diagnosis of attention deficit hyperactivity disorder and intellectual disability.UK Clinical Practice Research Datalink.Data on 80,103 pregnancies were used to study maternal primary care outcomes and were linked to 34,274 children with at least 4-year follow-up for neurodevelopmental outcomes. Women who initiated or continued antidepressants during pregnancy were more likely to have contact with primary and secondary health-care services during and after pregnancy and more likely to be prescribed an antidepressant 2 years following the end of pregnancy than women who did not initiate or continue antidepressants during pregnancy (odds ratioinitiation 2.16, 95% confidence interval 1.95 to 2.39; odds ratiocontinuation 2.40, 95% confidence interval 2.27 to 2.53). There was little evidence for any substantial association with autism (odds ratiomultivariableregression 1.10, 95% confidence interval 0.90 to 1.35; odds ratiopropensityscore 1.06, 95% confidence interval 0.84 to 1.32), attention deficit hyperactivity disorder (odds ratiomultivariableregression 1.02, 95% confidence interval 0.80 to 1.29; odds ratiopropensityscore 0.97, 95% confidence interval 0.75 to 1.25) or intellectual disability (odds ratiomultivariableregression 0.81, 95% confidence interval 0.55 to 1.19; odds ratiopropensityscore 0.89, 95% confidence interval 0.61 to 1.31) in children of women who continued antidepressants compared with those who discontinued antidepressants. There was inconsistent evidence of an association between initiation of antidepressants in pregnancy and diagnosis of autism in offspring (odds ratiomultivariableregression 1.23, 95% confidence interval 0.85 to 1.78; odds ratiopropensityscore 1.64, 95% confidence interval 1.01 to 2.66) but not attention deficit hyperactivity disorder or intellectual disability; however, but results were imprecise owing to smaller numbers.Several causal-inference analyses lacked precision owing to limited numbers. In addition, adherence to the prescribed treatment was not measured.Women prescribed antidepressants during pregnancy had greater service use during and after pregnancy than those not prescribed antidepressants. The evidence against any substantial association with autism, attention deficit hyperactivity disorder or intellectual disability in the children of women who continued compared with those who discontinued antidepressants in pregnancy is reassuring. Potential association of initiation of antidepressants during pregnancy with offspring autism needs further investigation.Further research on larger samples could increase the robustness and precision of these findings. These methods applied could be a template for future pharmaco-epidemiological investigation of other pregnancy-related prescribing safety concerns.This project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (15/80/19) and will be published in full in Health Technology Assessment; Vol. 27, No. 15. See the NIHR Journals Library website for further project information.About one in seven women experience depression during pregnancy. Left untreated, this may harm them and their unborn babies. However, the decision to take antidepressants during pregnancy is difficult because women often worry about the risks to their unborn baby. Research findings have been inconsistent, so women often do not have clear information to enable them to make informed decisions. We studied women’s and children’s outcomes after starting (compared with not starting) or continuing (compared with stopping) antidepressants in pregnancy. We used a large UK primary care database and several novel methods of analysis. We tracked 80,103 pregnancies of women with depression for up to 2 years after pregnancy. We also tracked 34,274 children from these pregnancies for at least 4 years to check for developmental outcomes. Women prescribed antidepressants were more likely than women not prescribed antidepressants to use general practice and mental health services during and after pregnancy, and to be prescribed antidepressants 2 years after pregnancy. This suggests that antidepressants were being prescribed to women with greater clinical need. Women who continued antidepressants in pregnancy had no higher likelihood than those who discontinued antidepressants of autism, attention deficit hyperactivity disorder or intellectual disability in their children. This should reassure women making the decision to continue taking their medications in pregnancy. Women who started antidepressants in pregnancy may possibly have had a slightly higher likelihood of autism in their children than those who did not start them. These findings were not seen in all analyses and were based on smaller numbers; therefore, they should be viewed with caution. Importantly, over 98 in every 100 children of women who initiated or continued antidepressants in pregnancy did not receive an autism diagnosis. The findings may help women and clinicians make informed decisions on treatment with antidepressants in pregnancy." @default.
- W4387661902 created "2023-10-17" @default.
- W4387661902 creator A5003345820 @default.
- W4387661902 creator A5014545124 @default.
- W4387661902 creator A5017723817 @default.
- W4387661902 creator A5018032551 @default.
- W4387661902 creator A5023169890 @default.
- W4387661902 creator A5027462458 @default.
- W4387661902 creator A5033829104 @default.
- W4387661902 creator A5048005452 @default.
- W4387661902 creator A5061002857 @default.
- W4387661902 creator A5075820729 @default.
- W4387661902 creator A5076039186 @default.
- W4387661902 creator A5093068267 @default.
- W4387661902 date "2023-09-01" @default.
- W4387661902 modified "2023-10-17" @default.
- W4387661902 title "Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children" @default.
- W4387661902 cites W1582406977 @default.
- W4387661902 cites W1760794340 @default.
- W4387661902 cites W1864226738 @default.
- W4387661902 cites W1922178820 @default.
- W4387661902 cites W1966526645 @default.
- W4387661902 cites W1971631504 @default.
- W4387661902 cites W1973231132 @default.
- W4387661902 cites W1973841871 @default.
- W4387661902 cites W1976820892 @default.
- W4387661902 cites W1981456496 @default.
- W4387661902 cites W1982984257 @default.
- W4387661902 cites W1985359478 @default.
- W4387661902 cites W1993631307 @default.
- W4387661902 cites W1997986489 @default.
- W4387661902 cites W1999081857 @default.
- W4387661902 cites W1999822211 @default.
- W4387661902 cites W2010747514 @default.
- W4387661902 cites W2011812102 @default.
- W4387661902 cites W2013126628 @default.
- W4387661902 cites W2026534761 @default.
- W4387661902 cites W2030175282 @default.
- W4387661902 cites W2032234096 @default.
- W4387661902 cites W2039857111 @default.
- W4387661902 cites W2040575369 @default.
- W4387661902 cites W2061360351 @default.
- W4387661902 cites W2061787422 @default.
- W4387661902 cites W2071055980 @default.
- W4387661902 cites W2071793679 @default.
- W4387661902 cites W2091973982 @default.
- W4387661902 cites W2095446576 @default.
- W4387661902 cites W2098095120 @default.
- W4387661902 cites W2104302525 @default.
- W4387661902 cites W2105930613 @default.
- W4387661902 cites W2119744351 @default.
- W4387661902 cites W2119852447 @default.
- W4387661902 cites W2120652135 @default.
- W4387661902 cites W2120734658 @default.
- W4387661902 cites W2121656227 @default.
- W4387661902 cites W2146050890 @default.
- W4387661902 cites W2164697276 @default.
- W4387661902 cites W2217811624 @default.
- W4387661902 cites W2223680920 @default.
- W4387661902 cites W2282746037 @default.
- W4387661902 cites W2290447957 @default.
- W4387661902 cites W2298338128 @default.
- W4387661902 cites W2300554243 @default.
- W4387661902 cites W2320427927 @default.
- W4387661902 cites W2337943012 @default.
- W4387661902 cites W2522891827 @default.
- W4387661902 cites W2606120593 @default.
- W4387661902 cites W2606395855 @default.
- W4387661902 cites W2615510373 @default.
- W4387661902 cites W2618699239 @default.
- W4387661902 cites W2735885455 @default.
- W4387661902 cites W2736514147 @default.
- W4387661902 cites W2751458036 @default.
- W4387661902 cites W2754833545 @default.
- W4387661902 cites W2765233788 @default.
- W4387661902 cites W2788337440 @default.
- W4387661902 cites W2794902751 @default.
- W4387661902 cites W2914016865 @default.
- W4387661902 cites W2927565051 @default.
- W4387661902 cites W2949674655 @default.
- W4387661902 cites W2953719564 @default.
- W4387661902 cites W2955859765 @default.
- W4387661902 cites W3036114761 @default.
- W4387661902 cites W3087280641 @default.
- W4387661902 cites W85516067 @default.
- W4387661902 cites W2128105361 @default.
- W4387661902 doi "https://doi.org/10.3310/aqtf4490" @default.
- W4387661902 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37842916" @default.
- W4387661902 hasPublicationYear "2023" @default.
- W4387661902 type Work @default.
- W4387661902 citedByCount "0" @default.
- W4387661902 crossrefType "journal-article" @default.
- W4387661902 hasAuthorship W4387661902A5003345820 @default.
- W4387661902 hasAuthorship W4387661902A5014545124 @default.
- W4387661902 hasAuthorship W4387661902A5017723817 @default.
- W4387661902 hasAuthorship W4387661902A5018032551 @default.
- W4387661902 hasAuthorship W4387661902A5023169890 @default.
- W4387661902 hasAuthorship W4387661902A5027462458 @default.